Skip to main content
← Back to all earnings calls

Theravance Biopharma, Inc. Q1 FY2026 Earnings Call

Theravance Biopharma, Inc. (TBPH)

Earnings Call FY2026 Q1 Call date: 2026-05-07 Concluded

Guidance

from the 8-K filed May 7, 2026
Metric Guided
Operating expenses reduction Initiated
2026
60%

Documents & deck